IP Library Patent Application 10504505
Patent Application
App. No. 10/504,505

Over-expression of extremozyme genes in pseudomonads and closely related bacteria

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
10/504,505
Abstract

An extremoyzme over-expression system in which Pseudomonads and closely related bacteria are used as host cells, and methods and kits for use thereof, extremozymes expressed therefrom.

Claims (68)

1 . A recombinant bacterial host cell genetically engineered to contain an expression vector operative therein,

the expression vector containing a nucleic acid containing an exogenous extremozyme coding sequence operably linked to a control sequence,

said host cell being capable of overexpressing said coding sequence, so as to produce said extremozyme at a total productivity of at least 1 g/L, when grown on a medium under conditions permitting expression,

characterized in that the bacterial host cell is selected from the Pseudomonads and closely related bacteria.

2 . An extremozyme overexpression system having:

a recombinant bacterial host cell,

an expression vector operative in said host cell, the expression vector containing a nucleic acid containing an exogenous extremozyme coding sequence operably linked to a control sequence,

said overexpression system being capable of overexpressing said coding sequence so as to produce said extremozyme at a total productivity of at least 1 g/L when grown on a medium under conditions permitting expression,

characterized in that the bacterial host cell is selected from the Pseudomonads and closely related bacteria.

3 . A process for overexpressing an extremozyme at a total productivity of at least 1 g/L, comprising the steps of:

(1) providing:

(a) a bacterial host cell selected from the Pseudomonads and closely related bacteria,

(b) an expression vector operative in said host cell and containing a nucleic acid containing an exogenous extremozyme coding sequence operably linked to a control sequence, and

(c) a medium;

(2) transforming said expression vector into said bacterial host cell to form a recombinant bacterial host cell; and

(3) growing said recombinant bacterial host cell on the medium under conditions permitting expression.

4 . A method for overexpressing an extremozyme, at a total productivity of at least 1 g/L, comprising:

(1) transforming an expression vector, containing a nucleic acid containing an exogenous extremozyme coding sequence operably linked to a control sequence, into a bacterial host cell selected from the Pseudomonads and closely related bacteria to produce a recombinant bacterial host cell; and

(2) growing said recombinant bacterial host cell on a medium under conditions permitting expression.

5 . Use, in a method for overexpressing an extremozyme at a total productivity of at least 1 g/L from a recombinant bacterial host cell grown on a medium under conditions permitting expression, of a recombinant bacterial host cell selected from the Pseudomonads and closely related bacteria.

6 . A commercial kit for overexpressing an extremozyme at a total productivity of at least 1 g/L, comprising:

(1) a quantity of a bacterial host cell selected from the Pseudomonads and closely related bacteria;

(2) a quantity of an expression vector operative in said bacterial host cell and containing a control sequence;

(3) instructions for inserting into said expression vector a nucleic acid containing an exogenous extremozyme coding sequence, so as to operably link the coding sequence to the control sequence, thereby preparing the expression vector;

(4) instructions for subsequently transforming said expression vector into said bacterial host cell to form a recombinant bacterial host cell; and

(5) instructions for growing said recombinant bacterial host cell on a medium under conditions permitting expression; and

(6) optionally, a quantity of said medium; and

(7) optionally, a quantity of an inducer for a regulated promoter where said control sequence utilizes said regulated promoter.

7 . A commercial kit for overexpressing an extremozyme at a total productivity of at least 1 g/L, comprising:

(1) a quantity of a bacterial host cell selected from the Pseudomonads and closely related bacteria,

(2) a quantity of an expression vector operative in said bacterial host cell and containing a control sequence and an exogenous extremozyme coding sequence operably linked thereto,

(3) instructions for transforming said expression vector into said bacterial host cell to form a recombinant bacterial host cell, and

(4) instructions for growing said recombinant bacterial host cell on a medium under conditions permitting expression; and

(5) optionally, a quantity of said medium; and

(6) optionally, a quantity of an inducer for a regulated promoter where said control sequence utilizes said regulated promoter.

8 . The extremozyme of any one of claims 1 - 7 wherein the extremozyme is selected from among any of the classes, IUBMB EC2-6.

9 . The extremozyme of claim 8 which is selected from among any of the extremophilic enzymes within any of the classes, IUBMB EC2-5.

10 . The extremozyme of claim 9 which is selected from among any of the extremophilic enzymes within any of the classes, IUBMB EC2-3.

11 . The extremozyme of claim 10 which is selected from among any of the extremophilic enzymes within the class IUBMB EC 3.

12 . The extremozyme of claim 11 which is selected from among any of the extremophilic enzymes within IUBMB EC 3.1-3.8.

13 . The extremozyme of claim 12 which is selected from among any of the extremophilic enzymes within IUBMB EC 3.1-3.2 or 3.4.

14 . The extremozyme of claim 13 which is selected from among any of the extremophilic enzymes within IUBMB EC 3.2 or 3.4.

15 . The extremozyme of claim 14 which is selected from among any of the extremophilic enzymes within IUBMB EC 3.2.1., 3.4.21, or 3.4.23.

16 . The extremozyme of claim 15 which is selected from the cellulases, amylases, serine endopeptidases, and aspartic endopeptidases.

17 . The extremozyme of claim 16 which is selected from the amylases, serine endopeptidases, and aspartic endopeptidases.

18 . The extremozyme of claim 17 which is selected from the alpha-amylases, pyrolysin, and thermopsin.

19 . The bacterial host cell of any one of claims 1 - 7 wherein the bacterial host cell is selected from Gram(−) Proteobacteria Subgroup 1.

20 . The bacterial host cell of any one of claims 1 - 7 wherein the bacterial host cell is selected from Gram(−) Proteobacteria Subgroup 2.

21 . The bacterial host cell of any one of claims 1 - 7 wherein the bacterial host cell is selected from Gram(−) Proteobacteria Subgroup 3.

22 . The bacterial host cell of any one of claims 1 - 7 wherein the bacterial host cell is selected from Gram(−) Proteobacteria Subgroup 5.

23 . The bacterial host cell of any one of claims 1 - 7 wherein the bacterial host cell is selected from Gram(−) Proteobacteria Subgroup 7.

24 . The bacterial host cell of any one of claims 1 - 7 wherein the bacterial host cell is selected from Gram(−) Proteobacteria Subgroup 12.

25 . The bacterial host cell of any one of claims 1 - 7 , 16 , and 18 wherein the bacterial host cell is selected from Gram(−) Proteobacteria Subgroup 15.

26 . The bacterial host cell of any one of claims 1 - 7 wherein the bacterial host cell is selected from Gram(−) Proteobacteria Subgroup 17.

27 . The bacterial host cell of any one of claims 1 - 7 , 16 , and 18 wherein the bacterial host cell is selected from Gram(−) Proteobacteria Subgroup 18.

28 . The expression vector of any one of claims 1 - 7 wherein the expression vector is selected from RSF1010 and derivatives thereof.

29 . The control sequence of any one of claims 1 - 7 wherein the control sequence contains a regulated promoter.

30 . The regulated promoter of claim 29 which is a negatively regulated promoter

31 . The negatively regulated promoter of claim 30 which is P tac .

32 . The growth of any one of claims 1 - 7 wherein said growth is done at or above a 10-Liter scale.

33 . The growth of any one of claims 1 - 7 wherein said growth under conditions permitting expression comprises growth of the recombinant bacterial host cells, said cells containing a regulated promoter operably linked to the extremozyme coding sequence, in the absence of an inducer therefor, followed by addition of such an inducer to the system.

34 . The medium of any one of claims 1 - 7 wherein said medium is selected from minimal media and carbon source-supplemented mineral salts media.

35 . The medium of claim 34 which is a carbon source-supplemented mineral salts medium.

36 . Any one of claims 3 - 4 further comprising separating, isolating, or purifying the extremozyme therefrom.

37 . The extremozyme expressed according to any one of claims 1 - 7 .

38 . Use in a biocatalytic process of an extremozyme expressed according to any one of claims 1 - 7 .

39 . The extremozyme of any one of claims 1 - 7 wherein the extremozyme is expressed in an inclusion body within the bacterial host cell and said inclusion body is thereafter solubilized.

40 . The extremozyme of any one of claims 1 - 7 and 39 wherein a refolding step is used to refold the extremozyme.

Assignments (2)
CHANGE OF NAME Recorded Mar 29, 2011
From: DOW GLOBAL TECHNOLOGIES INC.
To: DOW GLOBAL TECHNOLOGIES LLC
Reel/Frame 026045/0199 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 4, 2005
From: CHEW, LAWRENCE C.; TALBOT, HENRY W.; LEE, STACEY L.
To: DOW GLOBAL TECHNOLOGIES INC.
Reel/Frame 015660/0279 →